Loading
FT
Fresh Tracks Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Exploration Capital, LLC, was filed 11 Jun 2024.
Fresh Tracks Therapeutics, Inc.: what insiders have been doing
Fresh Tracks Therapeutics, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). Nothing new has been filed by managers of Fresh Tracks Therapeutics, Inc. in twelve months, the latest record being from 11 June 2024.
Our records for Fresh Tracks Therapeutics, Inc. go back to 2016, with 24 purchases and 7 sales on the open market in total.
Elsewhere in the same market, our signals recently picked up insider purchases at Heico Corp and Village Farms International, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
35
Thresholds
n/a
Buy Volume
€800,660
24 ops. · all time
Sell Volume
€91
7 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 11 June 2024
Declarations35 total
319,315 shares@ US$0.9439.1% of flowCommon StockSEC:0001213900-24-051866:0
Canonical exit: 5 Sept 2024 (T+90)
80 shares@ US$0.870.0% of flowCommon StockSEC:0001213900-24-048558:0
Canonical exit: 27 Aug 2024 (T+90)
6,879 shares@ US$0.910.8% of flowCommon StockSEC:0001213900-24-046344:0
Canonical exit: 19 Aug 2024 (T+90)
73,768 shares@ US$0.928.9% of flowCommon StockSEC:0001213900-24-045315:0
Canonical exit: 14 Aug 2024 (T+90)
320 shares@ US$0.890.0% of flowCommon StockSEC:0001213900-24-040869:0
Canonical exit: 4 Aug 2024 (T+90)
162,351 shares@ US$0.9219.8% of flowCommon StockSEC:0001213900-24-039764:0
Canonical exit: 30 Jul 2024 (T+90)
4,277 shares@ US$0.910.5% of flowCommon StockSEC:0001213900-24-035431:0
Canonical exit: 18 Jul 2024 (T+90)
2,188 shares@ US$0.880.3% of flowCommon StockSEC:0001213900-24-032240:0
Canonical exit: 8 Jul 2024 (T+90)
12,928 shares@ US$0.911.5% of flowCommon StockSEC:0001213900-24-030877:0
Canonical exit: 2 Jul 2024 (T+90)
51,634 shares@ US$0.906.1% of flowCommon StockSEC:0001213900-24-028916:0
Canonical exit: 25 Jun 2024 (T+90)
10 shares@ US$0.900.0% of flowCommon StockSEC:0001213900-24-024839:0
Canonical exit: 17 Jun 2024 (T+90)
5,703 shares@ US$0.910.7% of flowCommon StockSEC:0001213900-24-022246:0
Canonical exit: 9 Jun 2024 (T+90)
20,109 shares@ US$0.902.4% of flowCommon StockSEC:0001213900-24-018112:0
Canonical exit: 26 May 2024 (T+90)
49,951 shares@ US$0.885.8% of flowCommon StockSEC:0001213900-24-016223:0
Canonical exit: 20 May 2024 (T+90)
10,958 shares@ US$0.981.4% of flowCommon StockSEC:0001213900-24-004190:0
Canonical exit: 11 Apr 2024 (T+90)
38,017 shares@ US$0.984.8% of flowCommon StockSEC:0001213900-24-003009:0
Canonical exit: 8 Apr 2024 (T+90)
23,877 shares@ US$0.892.8% of flowCommon StockSEC:0001213900-24-001658:0
Canonical exit: 2 Apr 2024 (T+90)
47,000 shares@ US$0.845.1% of flowCommon StockSEC:0001213900-23-097429:0
Canonical exit: 19 Mar 2024 (T+90)
74 shares@ US$0.91100.0% of flowCommon StockSEC:0001628280-23-041229:0
35,000 sharesCommon StockSEC:0001628280-23-041230:0
7,579 shares@ US$0.85100.0% of flowCommon StockSEC:0001213900-23-093858:0
Canonical exit: 3 Mar 2024 (T+90)
36.44 shares@ US$0.8501100.0% of flowCommon StockSEC:0001628280-23-040639:0
55,000 sharesCommon StockSEC:0001628280-23-033916:0
20,000 sharesCommon StockSEC:0001628280-23-033914:0
15,180 shares@ US$0.22895.2% of flowCommon StockSEC:0000819050-22-000005:0
25 of 35 declarations
About Fresh Tracks Therapeutics, Inc.
Fresh Tracks Therapeutics, Inc. is a company focused on developing innovative treatments for psychiatric disorders. It is listed on the XNAS market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
